Symbol | YTM % | Volume | Price % | Coupon % | Maturity date | Outstanding amt | Face value | Min denom amt | Issuer |
---|---|---|---|---|---|---|---|---|---|
AA5QDALLERGAN FNDG 15/25 | 8.79% | 0 | 99.85% | 3.80% | 2025-03-15 | 130.22 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 8.14% | 50 K | 74.10% | 4.75% | 2045-03-15 | 53.51 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 7.72% | 24 K | 76.91% | 4.63% | 2042-10-01 | 67.49 M USD | 1,000.00 USD | 2,000.00 USD | Actavis, Inc. |
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 7.69% | 15 K | 77.85% | 4.85% | 2044-06-15 | 65.23 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 6.31% | 750 K | 89.19% | 4.55% | 2035-03-15 | 107.65 M USD | 1,000.00 USD | 2,000.00 USD | Allergan Funding SCS |
6.18% | 4.12 M | 99.92% | 3.80% | 2025-03-15 | 2.89 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.74% | 26 K | 90.47% | 3.20% | 2029-11-21 | 62.52 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.67% | 3.75 M | 85.40% | 4.25% | 2049-11-21 | 5.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.63% | 0 | 88.63% | 4.45% | 2046-05-14 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.53% | 0 | 92.07% | 4.70% | 2045-05-14 | 2.7 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.50% | 14 M | 90.14% | 4.40% | 2042-11-06 | 2.6 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.49% | 384 K | 93.64% | 4.88% | 2048-11-14 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.47% | 8 M | 92.40% | 4.63% | 2042-10-01 | 389.22 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.46% | 200 K | 93.20% | 4.75% | 2045-03-15 | 827.09 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.44% | 15.02 M | 100.71% | 5.50% | 2064-03-15 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.42% | 2.04 M | 88.79% | 4.05% | 2039-11-21 | 4 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.40% | 83 K | 94.81% | 4.85% | 2044-06-15 | 1.01 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.32% | 13.96 M | 100.89% | 5.40% | 2054-03-15 | 3 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.23% | 24.13 M | 104.28% | 5.60% | 2055-03-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.19% | 501 K | 101.51% | 5.35% | 2044-03-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.11% | 0 | 94.21% | 4.30% | 2036-05-14 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.05% | 0 | 99.72% | 3.60% | 2025-05-14 | 3.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
5.01% | 0 | 96.55% | 4.50% | 2035-05-14 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.96% | 1.86 M | 97.27% | 4.55% | 2035-03-15 | 1.68 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.84% | 25.32 M | 101.30% | 5.05% | 2034-03-15 | 3 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.83% | 18.04 M | 102.50% | 5.20% | 2035-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.65% | 22.89 M | 94.39% | 3.20% | 2029-11-21 | 5.44 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.58% | 4.85 M | 101.76% | 4.95% | 2031-03-15 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.53% | 27.18 M | 101.41% | 4.88% | 2030-03-15 | 1 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.45% | 7.07 M | 101.21% | 4.80% | 2029-03-15 | 2.5 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.41% | 3.41 M | 99.50% | 4.25% | 2028-11-14 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.39% | 5.41 M | 100.69% | 4.65% | 2028-03-15 | 1.25 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.38% | 11.25 M | 97.71% | 2.95% | 2026-11-21 | 3.99 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.33% | 0 | 98.72% | 3.20% | 2026-05-14 | 2 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
4.31% | 5.36 M | 100.92% | 4.80% | 2027-03-15 | 2.25 B USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
3.86% | 0 | 96.53% | 2.95% | 2026-11-21 | 9.24 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
3.84% | 0 | 96.06% | 2.63% | 2028-11-15 | 72.11 M EUR | 1,000.00 EUR | 100,000.00 EUR | Allergan Funding SCS | |
XXS162262122ALLERGAN FNDG 17/29 | 3.82% | 0 | 93.81% | 2.13% | 2029-06-01 | 36.46 M EUR | 1,000.00 EUR | 100,000.00 EUR | Allergan Funding SCS |
3.01% | 0 | 102.15% | 3.80% | 2025-03-15 | 1.27 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
3.00% | 0 | 90.21% | 1.25% | 2031-11-18 | 650 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
2.90% | 0 | 121.31% | 4.25% | 2049-11-21 | 4.95 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
2.88% | 0 | 126.76% | 4.75% | 2045-03-15 | 5 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
2.83% | 0 | 128.71% | 4.85% | 2044-06-15 | 100 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
2.77% | 0 | 97.54% | 2.13% | 2029-06-01 | 506.09 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
2.69% | 0 | 98.08% | 2.13% | 2028-11-17 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
2.69% | 0 | 99.79% | 2.63% | 2028-11-15 | 427.79 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
2.59% | 0 | 95.35% | 0.75% | 2027-11-18 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | AbbVie, Inc. | |
2.35% | 0 | 123.74% | 4.55% | 2035-03-15 | 1 K USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
— | — | — | 4.40% | 2042-11-06 | 1.1 M USD | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. | |
— | — | — | 3.80% | 2025-03-15 | — | 1,000.00 USD | 2,000.00 USD | AbbVie, Inc. |